Näytä suppeat kuvailutiedot

Dysregulation of secondary bile acid metabolism precedes islet autoimmunity and type 1 diabetes

Alves Marina Amaral; Xavier Ramnik J.; Hyötyläinen Tuulia; Sen Partho; Härkönen Taina; Dickens Alex M.; Knip Mikael; Oresic Matej; Honkanen Jarno; Vatanen Tommi; Lamichhane Santosh

dc.contributor.authorAlves Marina Amaral
dc.contributor.authorXavier Ramnik J.
dc.contributor.authorHyötyläinen Tuulia
dc.contributor.authorSen Partho
dc.contributor.authorHärkönen Taina
dc.contributor.authorDickens Alex M.
dc.contributor.authorKnip Mikael
dc.contributor.authorOresic Matej
dc.contributor.authorHonkanen Jarno
dc.contributor.authorVatanen Tommi
dc.contributor.authorLamichhane Santosh
dc.date.accessioned2022-12-13T15:17:46Z
dc.date.available2022-12-13T15:17:46Z
dc.identifier.urihttps://www.utupub.fi/handle/10024/173577
dc.description.abstract<p>The gut microbiota is crucial in the regulation of bile acid (BA) metabolism. However, not much is known about the regulation of BAs during progression to type 1 diabetes (T1D). Here, we analyzed serum and stool BAs in longitudinal samples collected at 3, 6, 12, 18, 24, and 36 months of age from children who developed a single islet autoantibody (AAb) (P1Ab; n = 23) or multiple islet AAbs (P2Ab; n = 13) and controls (CTRs; n = 38) who remained AAb negative. We also analyzed the stool microbiome in a subgroup of these children. Factor analysis showed that age had the strongest impact on both BA and microbiome profiles. We found that at an early age, systemic BAs and microbial secondary BA pathways were altered in the P2Ab group compared with the P1Ab and CTR groups. Our findings thus suggest that dysregulated BA metabolism in early life may contribute to the risk and pathogenesis of T1D.</p>
dc.language.isoen
dc.publisherELSEVIER
dc.titleDysregulation of secondary bile acid metabolism precedes islet autoimmunity and type 1 diabetes
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S2666379122003172
dc.identifier.urnURN:NBN:fi-fe2022121371179
dc.relation.volume3
dc.contributor.organizationfi=laitekeskus|en=Instrument Centre|
dc.contributor.organizationfi=Turun biotiedekeskus|en=Turku Bioscience Centre|
dc.contributor.organizationfi=biokemia|en=Biokemia|
dc.contributor.organizationfi=väestötutkimuskeskus|en=Centre for Population Health Research (POP Centre)|
dc.contributor.organizationfi=InFLAMES lippulaiva, tutkimus|en=InFLAMES Flagship, research|
dc.contributor.organization-code2607008
dc.contributor.organization-code2610101
dc.contributor.organization-code2607051
dc.contributor.organization-code2606304
dc.contributor.organization-code2609201
dc.converis.publication-id177112976
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/177112976
dc.identifier.eissn2666-3791
dc.identifier.jour-issn2666-3791
dc.okm.affiliatedauthorOresic, Matej
dc.okm.affiliatedauthorSen, Partho
dc.okm.affiliatedauthorLamichhane, Santosh
dc.okm.affiliatedauthorDickens, Alex
dc.okm.affiliatedauthorAmaral Alves, Marina
dc.okm.discipline318 Lääketieteen bioteknologiafi_FI
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline318 Medical biotechnologyen_GB
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeJournal article
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.articlenumber100762
dc.relation.doi10.1016/j.xcrm.2022.100762
dc.relation.ispartofjournalCell Reports Medicine
dc.relation.issue10
dc.year.issued2022


Aineistoon kuuluvat tiedostot

Thumbnail

Aineisto kuuluu seuraaviin kokoelmiin

Näytä suppeat kuvailutiedot